Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

EGX:PHAR Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	362.82	1,433	1,295	675.8	482.97	311.59
Cash & Short-Term Investments	362.82	1,433	1,295	675.8	482.97	311.59
Cash Growth	-76.94%	10.66%	91.68%	39.93%	55.00%	-57.48%
Accounts Receivable	2,421	1,578	1,331	1,153	946.58	792.04
Other Receivables	-	-	-	0.67	12.7	10.95
Receivables	4,164	3,366	3,049	2,359	1,807	1,172
Inventory	4,047	3,887	3,585	2,242	2,162	1,818
Other Current Assets	373.34	327.75	197.91	209.39	130.2	234.32
Total Current Assets	8,947	9,015	8,127	5,486	4,582	3,536
Property, Plant & Equipment	8,203	8,205	6,748	4,024	1,838	1,372
Long-Term Investments	904.36	675.87	465.26	466.49	352.34	326.84
Other Intangible Assets	38.47	40.14	32.05	2.3	1.57	-
Long-Term Deferred Tax Assets	338.85	337.61	-	-	-	-
Other Long-Term Assets	-	-	-	-0	-	-
Total Assets	18,432	18,273	15,373	9,979	6,774	5,235

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	904.65	766.18	381.8	138.42	185.56	60.37
Accrued Expenses	543.26	645.86	184.12	100.83	88.48	63.29
Short-Term Debt	5,435	5,041	5,793	2,083	2,047	1,234
Current Portion of Leases	0.4	0.38	0.3	2.19	1.39	-
Current Income Taxes Payable	423.39	388.95	344.85	184.98	106.82	110.62
Current Unearned Revenue	73.22	73.22	-	-	-	-
Other Current Liabilities	1,080	864.13	540.15	321.05	230.07	192
Total Current Liabilities	8,460	7,780	7,244	2,831	2,660	1,661
Long-Term Debt	4,022	3,759	3,425	2,832	812.13	529.07
Long-Term Leases	11.87	11.98	10.71	0.13	0.79	-
Long-Term Deferred Tax Liabilities	257.76	190.77	35.83	54.79	58.94	71.84
Total Liabilities	12,751	11,741	10,715	5,718	3,532	2,261

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,688	1,688	1,488	1,488	991.71	991.71
Retained Earnings	2,982	3,549	1,904	1,508	1,286	1,047
Comprehensive Income & Other	1,007	1,007	1,262	1,262	961.82	931.82
Total Common Equity	5,677	6,243	4,654	4,257	3,239	2,971
Minority Interest	4	288.7	3.82	3.39	3.05	2.82
Shareholders' Equity	5,681	6,532	4,658	4,261	3,242	2,973
Total Liabilities & Equity	18,432	18,273	15,373	9,979	6,774	5,235

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	9,469	8,812	9,229	4,918	2,862	1,763
Net Cash (Debt)	-9,106	-7,379	-7,933	-4,242	-2,379	-1,452
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-54.52	-45.54	-53.33	-28.52	-23.99	-14.64
Filing Date Shares Outstanding	168.76	168.76	148.76	148.76	99.17	99.17
Total Common Shares Outstanding	168.76	168.76	148.76	148.76	99.17	99.17
Working Capital	487.52	1,235	883.47	2,655	1,922	1,876
Book Value Per Share	33.64	37.00	31.28	28.62	32.66	29.95
Tangible Book Value	5,638	6,203	4,622	4,255	3,238	2,971
Tangible Book Value Per Share	33.41	36.76	31.07	28.60	32.65	29.95
Land	83.19	83.19	83.19	83.19	83.19	-
Buildings	2,086	2,049	543.43	542.86	543.84	-
Machinery	3,932	2,778	2,158	1,983	1,892	-
Construction In Progress	3,984	4,901	5,694	3,058	866.16	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error